Tariffs are the latest disruption facing medtech companies, but they won’t be the last. Protectionism, extreme weather events, geopolitical tensions, and regulatory shifts will keep coming and expose companies to ever-evolving risks. Some medtech companies have started putting measures in place to reduce tariffs and comply with new trade requirements. But they shouldn’t stop there.

Tomorrow’s winners in medtech will be those that look beyond trade compliance and build resilience muscles along the supply chain to meet all types of disruption and risk. Specifically, they should focus on three priorities:

• Build a full supply chain command center.

• Improve transparency and map supplier networks, using AI.

• Redesign the network with future shocks in mind.

Trade compliance as a foundati

See Full Page